Monsanto Company (NYSE:MON) – Equities researchers at Jefferies Group dropped their Q4 2017 earnings estimates for shares of Monsanto Company in a note issued to investors on Wednesday, Zacks Investment Research reports. Jefferies Group analyst L. Alexander now anticipates that the basic materials company will post earnings of ($0.26) per share for the quarter, down from their prior estimate of $0.04. Jefferies Group currently has a “Buy” rating and a $128.00 price target on the stock.
Monsanto Company (NYSE:MON) last posted its earnings results on Wednesday, April 5th. The basic materials company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.40. The company earned $5.07 billion during the quarter, compared to analysts’ expectations of $4.73 billion. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The firm’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the firm earned $2.42 earnings per share. WARNING: This piece of content was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/04/21/q4-2017-earnings-estimate-for-monsanto-company-issued-by-jefferies-group-mon-updated.html.
Several other analysts also recently weighed in on the company. Citigroup Inc restated a “neutral” rating and set a $125.00 target price (up from $122.00) on shares of Monsanto Company in a research note on Friday, April 14th. Royal Bank of Canada restated a “hold” rating and set a $120.00 target price on shares of Monsanto Company in a research note on Friday, April 7th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research note on Wednesday, April 5th. Vetr upgraded Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 target price for the company in a research note on Monday, April 3rd. Finally, Zacks Investment Research upgraded Monsanto Company from a “hold” rating to a “buy” rating and set a $128.00 target price for the company in a research note on Tuesday, March 7th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. Monsanto Company currently has an average rating of “Buy” and an average price target of $118.94.
Shares of Monsanto Company (NYSE:MON) traded down 0.15% during midday trading on Friday, hitting $115.55. The stock had a trading volume of 1,186,611 shares. The stock has a market cap of $50.70 billion, a P/E ratio of 26.58 and a beta of 0.93. The stock has a 50-day moving average price of $114.50 and a 200-day moving average price of $107.42. Monsanto Company has a 12-month low of $88.76 and a 12-month high of $116.60.
Several large investors have recently added to or reduced their stakes in MON. First PREMIER Bank boosted its stake in Monsanto Company by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock worth $102,000 after buying an additional 36 shares during the period. Whitnell & Co. boosted its stake in Monsanto Company by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock worth $111,000 after buying an additional 256 shares during the period. Hartford Financial Management Inc. acquired a new stake in Monsanto Company during the first quarter worth $113,000. Mascoma Wealth Management LLC acquired a new stake in Monsanto Company during the fourth quarter worth $115,000. Finally, JNBA Financial Advisors boosted its stake in Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the basic materials company’s stock worth $121,000 after buying an additional 227 shares during the period. 75.18% of the stock is currently owned by institutional investors.
In other news, COO Brett D. Begemann sold 80,940 shares of Monsanto Company stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $116.13, for a total transaction of $9,399,562.20. Following the sale, the chief operating officer now owns 148,247 shares of the company’s stock, valued at $17,215,924.11. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Michael K. Stern sold 5,670 shares of Monsanto Company stock in a transaction that occurred on Wednesday, January 25th. The shares were sold at an average price of $110.00, for a total value of $623,700.00. Following the sale, the chief executive officer now directly owns 20,534 shares in the company, valued at approximately $2,258,740. The disclosure for this sale can be found here. Insiders sold 249,540 shares of company stock worth $28,947,034 in the last three months. 0.79% of the stock is currently owned by corporate insiders.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, April 7th will be issued a $0.54 dividend. The ex-dividend date is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.87%. Monsanto Company’s dividend payout ratio is currently 58.86%.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.